1.Study on the therapeutic effects of interferon and gamma-globulin in experimental Pneumocystis carinii pneumonia.
Dae Whan SHIN ; Dae Young KANG ; Young Ha LEE ; Young Eun NA ; Keon Jung YUN
The Korean Journal of Parasitology 1992;30(3):219-226
This study was performed to observe the therapeutic effects of interferon-gamma(IFN-gamma) and gamma-globulin(gamma-globulin) in experimental Pneumocystis carinii pneumonia of immune suppressed mice. After 9 weeks, trimethoprim-sulfamethoxazole(TMP-SMZ; 10-50 mg/mouse/day), mouse IFN-gamma(5 x 10(4) units/mouse/day) and mouse gamma-globulin(20 mg/mouse/day) were administered to the mice for 3 weeks by the experimental group. The therapeutic efficacy was evaluated by body weights, histopathologic and electron microscopic findings of the lungs, and number of P. carinii cysts by Gomori's methenamine silver stain. Body weights of the mice were significantly increased in the group of combination therapy of TMP-SMZ with IFN-gamma or gamma-globulin, and in the group of TMP-SMZ treatment (p < 0.05), however, little effect was found in the group of gamma-globulin alone. Histopathologic findings of P. carinii pneumonia were much improved in the group of combination therapy of TMP-SMZ with IFN-gamma. Treatment with either TMP-SMZ or IFN-gamma significantly reduced the number of cysts in the P. carinii pneumonia, but gamma-globulin alone was ineffective. In electron microscopic findings of P. carinii pneumonia, the number of trophozoites and cysts were reduced by treatment with either TMP-SMZ or IFN-gamma, and most of the cysts were empty or containing one or two intracystic bodies. The present results suggested, that combination therapy of TMP-SMZ with IFN-gamma had synergistic effects in treatment of P. carinii pneumonia in experimental mice.
Drug-Synergism
;
Drug-Therapy,-Combination
;
English-Abstract
;
Gamma-Globulins-administration-and-dosage
;
Interferon-Type-II-administration-and-dosage
;
Mice-
;
Trimethoprim-Sulfamethoxazole-Combination-administration-and-dosage
;
*Gamma-Globulins-therapeutic-use
;
*Interferon-Type-II-therapeutic-use
;
*Pneumonia,-Pneumocystis-carinii-therapy
;
Gamma-Globulins
;
Trimethoprim-Sulfamethoxazole-Combination
;
Interferon-Type-II
2.Caspofungin in salvage treatment of severe pneumocystis pneumonia: case report and literature review.
Xiang-dong MU ; Cheng-li QUE ; Bing HE ; Guang-fa WANG ; Hai-chao LI
Chinese Medical Journal 2009;122(8):996-999
Aged
;
Echinocandins
;
administration & dosage
;
therapeutic use
;
Humans
;
Leukemia, Myelomonocytic, Chronic
;
pathology
;
Lipopeptides
;
Male
;
Pneumonia, Pneumocystis
;
diagnosis
;
drug therapy
;
pathology
;
Trimethoprim, Sulfamethoxazole Drug Combination
;
administration & dosage
;
therapeutic use
;
Uremia
;
pathology
3.Pharmacokinetics of sulfamethoxazole in healthy Han volunteers living at plain and in native Han and Tibetan healthy volunteers living at high altitude.
Xiang-yang LI ; Yong-nian LIU ; Yong-ping LI ; Ming YUAN ; Jun-bo ZHU
Acta Pharmaceutica Sinica 2011;46(9):1117-1122
The paper is to report the pharmacokinetics of sulfamethoxazole in healthy Han volunteers living at plain (PH) and native Han and Tibetan healthy volunteers living at high altitude (HNH and HNT). After healthy volunteers were administrated orally cotrimoxazole tablets, plasma concentration of sulfamethoxazole and metabolite N4-acetylsulfamethoxazole was determined by RP-HPLC, and plasma concentration-time data were analyzed by DAS 2.0 software to get the related pharmacokinetic parameters. The main pharmacokinetic parameters t(1/2) of sulfamethoxazole in PH, HNH and HNT were, respectively, 9.30 +/- 1.11, 10.99 +/- 1.23 and 10.44 +/- 1.05 h; tmax were 1.4 +/- 0.3, 2.0 +/- 1.1 and 1.8 +/- 0.4 h; Cmax were 94.42 +/- 15.26, 89.33 +/- 7.67 and 87.43 +/- 11.61 micro x mL(-1); AUC(0-t) were 1202.5 +/- 238.3, 1 434.7 +/- 193.9 and 1302.8 +/- 103.0 microg x h x mL(-1); AUC(0-infinity) were 1240.7 +/- 255.3, 1511.5 +/- 211.9 and 1363.9 +/- 116.5 microg x h x mL(-1); CL were 1.01 +/- 0.22, 0.81 +/- 0.12 and 0.89 +/- 0.08 L x h(-1) x kg(-1); V were 13.27 +/- 1.73, 12.81 +/- 2.15 and 13.28 +/- 1.20 L x kg(-1). Sulfamethoxazole pharmacokinetic parameters of HNH and HNT were significantly different from that of PH. The t(1/2) was significantly higher and the CL was significantly lower in HNH and HNT than that in PH, and the AUC(0-infinity) was significantly lower in HNT compared with HNH. This study found significant changes in the disposition of sulfamethoxazole under the special environment of high altitude hypoxia. This finding may provide some references for clinical rational application of sulfamethoxazole in HNH and HNT.
Adult
;
Altitude
;
Anti-Infective Agents
;
administration & dosage
;
pharmacokinetics
;
Area Under Curve
;
Asian Continental Ancestry Group
;
ethnology
;
China
;
ethnology
;
Chromatography, High Pressure Liquid
;
Erythrocytes
;
metabolism
;
Humans
;
Hypoxia
;
metabolism
;
Male
;
Protein Binding
;
Sulfamethoxazole
;
analogs & derivatives
;
blood
;
pharmacokinetics
;
Tablets
;
Trimethoprim, Sulfamethoxazole Drug Combination
;
administration & dosage
;
pharmacokinetics
;
Young Adult